At Apeiron Pharma, we develop and supply a portfolio of high-value healthcare products tailored to the needs of international partners, including generic pharmaceutical products both over-the-counter (OTC) and prescription, with a strong focus on difficult-to-manufacture formulations, niche molecules, and specialized dosage forms or presentations designed to create a clear competitive advantage in the market; in addition, we offer a range of medical devices fully compliant with the European Medical Device Regulation (MDR – EU 2017/745), available as ready-to-market solutions or developed under private label with full technical and regulatory support; our portfolio is completed by food supplements and cosmetic products, all designed with a focus on quality, safety, and market trends, and available through flexible private label solutions to support our partners in building differentiated and competitive product lines.